HARVARD BIOSCIENCE INC (HBIO) Stock Income Statement
NASDAQ:HBIO - Nasdaq - US4169061052 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 91.40M | 94.14M | 112.25M | 113.30M | 118.90M | |||
| Cost Of Goods | 39.22M | 39.33M | 45.86M | 51.00M | 51.30M | |||
| Gross Profit | 52.18M | 54.81M | 66.39M | 62.30M | 67.70M | |||
| Operating Expenses | 56.94M | 60.19M | 64.11M | 67.10M | 64.20M | |||
| Research and Development | 9.84M | 10.41M | 11.76M | 12.30M | 10.80M | |||
| Selling, General, and Administrative Expenses | 41.99M | 43.70M | 46.82M | 48.60M | 47.70M | |||
| Operating Income | -4.76M | -5.38M | 2.29M | -4.70M | 3.40M | |||
| Interest Income/Expense | -3.54M | -4.80M | -4.22M | -2.50M | -1.50M | |||
| Other Income/Expense | -834.00K | -652.00K | -227.00K | 300.00K | -700.00K | |||
| Non Recurring Items | -48.84M | -835.00K | -391.00K | -2.20M | -1.30M | |||
| Income Before Taxes | -57.98M | -11.66M | -2.56M | -9.20M | -100.00K | |||
| Income Tax | 76.00K | 740.00K | 859.00K | 300.00K | 100.00K | |||
| Net Income | -58.05M | -12.40M | -3.42M | -9.50M | -300.00K | |||
| EBITDA | 2.27M | 1.78M | 9.28M | 2.87M | 11.02M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.32 | -0.28 | -0.08 | -0.23 | -0.01 | |||
| Non GAAP EPS | 0.03 | 0.06 | 0.15 | 0.12 | 0.25 | |||
| Statistics | ||||||||
| Gross Profit Margin | 57.09% | 58.22% | 59.15% | 54.99% | 56.94% | |||
| Profit Margin | -63.52% | -13.18% | -3.04% | -8.38% | -0.25% | |||
| Operating Profit Margin | -5.21% | -5.71% | 2.04% | -4.15% | 2.86% | |||
All data in USD